299 related articles for article (PubMed ID: 17253543)
1. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis.
Lirussi F; Mastropasqua E; Orando S; Orlando R
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD005165. PubMed ID: 17253543
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis.
Lirussi F; Azzalini L; Orando S; Orlando R; Angelico F
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD004996. PubMed ID: 17253535
[TBL] [Abstract][Full Text] [Related]
3. Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis.
Orlando R; Azzalini L; Orando S; Lirussi F
Cochrane Database Syst Rev; 2007 Jan; (1):CD005160. PubMed ID: 17253541
[TBL] [Abstract][Full Text] [Related]
4. Bariatric surgery for non-alcoholic steatohepatitis in obese patients.
Chavez-Tapia NC; Tellez-Avila FI; Barrientos-Gutierrez T; Mendez-Sanchez N; Lizardi-Cervera J; Uribe M
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD007340. PubMed ID: 20091629
[TBL] [Abstract][Full Text] [Related]
5. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
[TBL] [Abstract][Full Text] [Related]
6. Probiotics for patients with hepatic encephalopathy.
McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
[TBL] [Abstract][Full Text] [Related]
7. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
Angelico F; Burattin M; Alessandri C; Del Ben M; Lirussi F
Cochrane Database Syst Rev; 2007 Jan; (1):CD005166. PubMed ID: 17253544
[TBL] [Abstract][Full Text] [Related]
8. Probiotics for people with hepatic encephalopathy.
Dalal R; McGee RG; Riordan SM; Webster AC
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008716. PubMed ID: 28230908
[TBL] [Abstract][Full Text] [Related]
9. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Goh ET; Stokes CS; Sidhu SS; Vilstrup H; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2018 May; 5(5):CD012410. PubMed ID: 29762873
[TBL] [Abstract][Full Text] [Related]
10. Anabolic-androgenic steroids for alcoholic liver disease.
Rambaldi A; Gluud C
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD003045. PubMed ID: 17054157
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.
Lombardi R; Onali S; Thorburn D; Davidson BR; Gurusamy KS; Tsochatzis E
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011640. PubMed ID: 28358980
[TBL] [Abstract][Full Text] [Related]
12. Propylthiouracil for alcoholic liver disease.
Rambaldi A; Gluud C
Cochrane Database Syst Rev; 2005 Oct; (4):CD002800. PubMed ID: 16235302
[TBL] [Abstract][Full Text] [Related]
13. Anabolic-androgenic steroids for alcoholic liver disease.
Rambaldi A; Iaquinto G; Gluud C
Cochrane Database Syst Rev; 2003; (1):CD003045. PubMed ID: 12535450
[TBL] [Abstract][Full Text] [Related]
14. Propylthiouracil for alcoholic liver disease.
Rambaldi A; Gluud C
Cochrane Database Syst Rev; 2002; (2):CD002800. PubMed ID: 12076451
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. S-adenosyl-L-methionine for alcoholic liver diseases.
Rambaldi A; Gluud C
Cochrane Database Syst Rev; 2006 Apr; (2):CD002235. PubMed ID: 16625556
[TBL] [Abstract][Full Text] [Related]
17. Weight reduction for non-alcoholic fatty liver disease.
Peng L; Wang J; Li F
Cochrane Database Syst Rev; 2011 Jun; (6):CD003619. PubMed ID: 21678341
[TBL] [Abstract][Full Text] [Related]
18. Herbal medicines for fatty liver diseases.
Liu ZL; Xie LZ; Zhu J; Li GQ; Grant SJ; Liu JP
Cochrane Database Syst Rev; 2013 Aug; (8):CD009059. PubMed ID: 23975682
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Probiotics (MCP
Mohamad Nor MH; Ayob N; Mokhtar NM; Raja Ali RA; Tan GC; Wong Z; Shafiee NH; Wong YP; Mustangin M; Nawawi KNM
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579068
[TBL] [Abstract][Full Text] [Related]
20. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM
World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
